Less than 20 percent of
lung cancer cases are detected in the relatively treatable Stage I, but
healthcare technology company Zenosense, Inc. (OTCQB: ZENO) is hoping to change
that. On December 16, 2014, the company announced its intention to conduct a
400 person lung cancer detection trial in collaboration with a university
hospital near Madrid, Spain. Using its proprietary non-invasive, cost effective
detection devices, the company aims to identify distinctive volatile organic
compounds (VOCs) by analyzing patients’ exhaled breath.
Zenosense is hoping to use
a technique based on natural processes to decrease the costs associated with
lung cancer detection. Sniffing out diseases is a proven diagnostic method, as
highly trained dogs have been used in the past to recognize the VOCs associated
with prostate cancer with 98 percent accuracy. In the same way, the company’s
device uses a great number of sensors to detect VOCs that are unique to a
particular illness, such as lung cancer.
“I believe that a
cost-effective lung cancer detector proven as meeting or exceeding the accuracy
of low dose Computed Tomography (CT) scanning will have wide appeal and be in
significant demand,” said Carlos Gil, Chief Executive Officer of Zenosense.
Zenosense expects the
trial to take nine months, during which the company will examine samples from
multiple groups to ensure proper functionality. If successful, the company
intends to increase the size of the trial population in the future.
According to the American
Cancer Society, there will be approximately 221,000 new cases of lung cancer,
as well as an estimated 158,000 lung cancer related deaths, in the United
States during this year alone. The same report indicates that patients who had
their cancer diagnosed during Stage I development had an increased 5-year
survival rate of approximately 61 percent over those who were diagnosed in
Stage II.
With Zenosense’s lung
cancer detection trial officially scheduled, a significant step forward in
diagnostic techniques and lung cancer survivability could be just around the
corner.
For more information on
the company, visit www.zenosense.net
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment